
Omega 3 fatty acids
are polyunsaturated fats that we find mainly in oily fish.
They
are also known as essential or indispensable
fatty acids, because our organism cannot manufacture them on its own
and yet
they are indispensable for its correct functioning and for the
prevention of
certain illnesses.
With current trends
and the progressive abandonment of the Mediterranean diet we are
consuming less
of this type of fats, which is why it is necessary to take them in
enriched
food substances, such as milk.
- Omega 3
DHA: present in maternal milk and critical (in the early stages) for
the
development of the cognitive system and visual function.
- Omega 3
EPA: helps to preserve the health of your cardiovascular
system.
Olive oil presents
a differential effect compared to other vegetable oils rich in
polyunsaturated
or monounsaturated fatty acids, being very similar to the performance
mechanism
of omega 3 acids.
They all produce a
reduction in LDL Cholesterol (bad cholesterol), while only
olive oil prevents
the reduction of the HDL
Cholesterol (good cholesterol).
However,
it is only virgin olive oil that
inhibits the oxidation of the LDL thanks to its high content in
antioxidant
compounds, particularly tocopherols and phenolic compounds.
Finally, an
immune-regulating effect on arteriosclerosis has been observed in
virgin olive
oil, capable of modulating the inflammation processes on artery walls
by
inhibiting the production of cytokines, the adhesion of leucocytes on
the arterial
wall and platelet aggregation.
Olive oil, through
oleic acid and its antioxidant components, affects different processes
related
to the apparition of a thrombosis. Oleic
acid reduces blood pressure, protects the endothelium and diminishes
the inflammatory
process.
With regard to the
phenomena of platelet aggregation (which favours the apparition of a
blood
clot), olive oil reduces it: it increases the concentration thresholds
for
compounds that induce said aggregation such as collagen and adrenaline;
reduces
the liberation of thromboxane A2 (key to platelet aggregation); and
reduces the
levels of Factor von Willebrand (Factor vW) which keeps the platelets
attached
to the vessel wall.
Similarly, it
intervenes in the coagulation process.
It reduces procoagulant
factor VII, the Tissue Factor Pathway Inhibitor
(TFPI), a substance fundamental to the modulation of the Tissue Factor
effect
(TF), principal prothrombotic component of broken plaque.
Folic
acid reduces damage to artery walls.
Folic acid could
diminish the risk of cardiac disease by preventing damage to the
internal
artery walls, according to British researchers.
Folic acid from
Vitamin B can reduce homocysteine, a substance found in the blood which
has
been related to cardiac disease. The
study concludes that too much homocysteine, which normally forms when
protein
collapses, could provoke oxidisation damage in the endothelium.